Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings

Clin Hemorheol Microcirc. 2015;61(2):135-41. doi: 10.3233/CH-151985.

Abstract

Purpose: To evaluate the use of contrast-enhanced ultrasound (CEUS) after irreversible electroporation (IRE) of prostatic cancer tissue to assess the ablation status by depicting microvascularisation in the ablation area.

Materials and methods: Retrospective evaluation of CEUS of 13 patients (mean age: 61.4 ± 7.5 years) with histologically confirmed prostatic cancer who underwent percutaneous IRE. In the course of clinical routine, the tumor lesions were documented before, immediately after, and 1 day after the ablationusing color-coded transabdominal and transrectal CEUS. The obtained image data (DICOM loops and images) were subsequently evaluated by 2 experienced radiologists and assessed with regard to micro vascularisation by means of a 5-point scale.

Results: CEUS images showed significantly reduced microcirculation of the lesions (mean 0.9 ± 0.6 cm (0.5-1.5 cm) after IRE. Microcirculation was reduced from 2.15 ± 0.56 prior to ablation to 0.65 ± 0.63 (p < 0.001) immediately after the ablation and to 0.27 ± 0.44 one day after IRE (p < 0.001).

Conclusion: This study showed rapid and significant reduction of the microcirculation in the ablation area afterpercutaneous IRE of prostatic cancer tissue.

Keywords: Irreversible electroporation; contrast-enhanced ultrasound; percutaneous ablation; prostate cancer.

MeSH terms

  • Aged
  • Capillary Permeability
  • Contrast Media
  • Electrochemotherapy*
  • Humans
  • Male
  • Microvessels / diagnostic imaging
  • Middle Aged
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / drug therapy*
  • Retrospective Studies
  • Ultrasonography

Substances

  • Contrast Media